Paul LaViolette is the managing partner, chief operating officer, and innovation growth board chairman at SV Health Investors. He brings over 34 years of global medical technology management experience. Paul was most recently chief operating officer at Boston Scientific Corporation (BSC), an $8 billion medical device leader. During his 15 years at BSC, he also served as group president cardiovascular, group president endosurgery, president-cardiology, and president-international as the company grew revenues over 20 times. Paul integrated two dozen acquisitions and led extensive product development, operations, and worldwide commercial organizations. He previously held marketing and general management positions at CR Bard and various marketing roles at Kendall (Covidien).
Paul received his bachelor’s degree in psychology from Fairfield University and his master of business administration from Boston College.